Elevated hs-cTnI prior to tumor resection surgery was associated with a higher rate of all-cause death and MACE at long-term follow-up in colorectal cancer patients irrespective of whether they have received chemoradiotherapy prior to surgery. Here, TNNI3 is linked to neoplasm.